YSEI SHH-250GSD Integrated Drug Stability Testing Chamber

Overview

The YSEI SHH-250GSD Integrated Drug Stability Testing Chamber is an engineered environmental simulation system designed specifically for pharmaceutical stability studies in accordance with international regulatory frameworks. It operates on a tri-parameter control architecture—precisely regulating temperature, relative humidity, and photometric illumination—within a single, validated chamber space. Its core function is to replicate long-term, accelerated, and intermediate storage conditions as defined by ICH Q1A(R3) guidelines, enabling quantitative assessment of chemical degradation kinetics, physical property changes, and shelf-life determination for active pharmaceutical ingredients (APIs), finished dosage forms, and parenteral solutions—including large-volume infusions requiring low-humidity testing at 40°C / 20% RH. The chamber employs a dual-loop PID-controlled refrigeration/humidification system with redundant sensor arrays (NIST-traceable Pt100 RTDs and capacitive RH sensors), ensuring spatial uniformity (±0.5°C temperature, ±3% RH) across the full working volume. Structural integrity is maintained via double-wall insulated stainless steel construction with non-outgassing internal surfaces, minimizing particulate generation and supporting GMP-aligned cleanroom integration.

Key Features

• Tri-variable environmental control: Simultaneous, independent regulation of temperature (0–60°C), humidity (10–85% RH), and illumination (0–10,000 lux, UV-filtered LED array meeting ICH Q1B spectral requirements)
• Regulatory-grade data integrity: Onboard real-time logging with timestamped records stored internally (≥36 months at 10-min intervals); optional thermal micro-printer provides auditable hard-copy output with user-configurable print cycles
• Fail-safe hardware protection suite: Independent high-limit thermostat, humidifier dry-run cutoff, compressor thermal overload relay, and configurable SMS-based alarm notification (via integrated GSM module) for power interruption, temperature excursion (>±2°C), or humidity deviation (>±5% RH)
• Energy-optimized architecture: High-efficiency scroll compressor, low-power LED illumination, and adaptive fan-speed control reduce operational load—measured power draw ≤1.8 kW under sustained 40°C / 75% RH operation
• Acoustically engineered enclosure: Vibration-dampened mounting, insulated chamber walls, and low-noise axial fans maintain acoustic emissions ≤55 dB(A) at 1-meter distance—suitable for shared laboratory environments

Sample Compatibility & Compliance

The SHH-250GSD accommodates standard stability protocols for solid oral dosage forms (tablets, capsules), sterile injectables, ointments, suspensions, and lyophilized products. Its 250 L internal volume includes removable, adjustable stainless-steel shelves (one light-sensitive shelf fitted with UV-blocking acrylic cover per ICH Q1B). All materials in contact with the test environment comply with USP Class VI biocompatibility standards and exhibit no volatile organic compound (VOC) emission under operating conditions. The system is pre-validated for conformance with ICH Q1A(R3) long-term (25°C / 60% RH), accelerated (40°C / 75% RH), and intermediate (30°C / 65% RH) conditions, as well as specialized low-RH testing (40°C / 20% RH) required for large-volume parenterals. Full IQ/OQ documentation packages—including sensor calibration certificates, uniformity mapping reports, and protocol execution records—are available to support FDA, EMA, and NMPA submissions.

Software & Data Management

While the SHH-250GSD operates as a stand-alone unit with embedded firmware, it supports external data export via USB interface (CSV format) and optional RS-485/Modbus RTU connectivity for integration into centralized Laboratory Information Management Systems (LIMS) or SCADA platforms. Audit trail functionality complies with FDA 21 CFR Part 11 requirements, including electronic signature capability, immutable record retention, and user-access-level permissions (administrator, operator, reviewer). Historical trend visualization—including overlayable temperature/humidity/light intensity curves—is accessible via the front-panel LCD interface or exported datasets. All calibration events, alarm logs, and maintenance actions are time-stamped and retained within the device memory for ≥3 years.

Applications

• ICH-compliant stability studies for registration dossiers (CTD Module 3)
• Real-time and accelerated shelf-life estimation per USP and Ph. Eur. 5.20
• Photostability screening per ICH Q1B (optionally equipped with irradiance monitoring)
• Excipient compatibility testing under controlled hygrothermal stress
• Process validation support for packaging integrity assessments (e.g., blister permeability under variable RH)
• GMP-aligned storage condition qualification for warehouse and stability storage rooms

FAQ

Does the SHH-250GSD meet FDA 21 CFR Part 11 requirements for electronic records?

Yes—the system supports audit trails, electronic signatures, and role-based access control when configured with optional software modules and external authentication infrastructure.
Can the chamber perform low-humidity testing at 40°C for large-volume parenterals?

Yes—it is explicitly engineered for 40°C / 20% RH operation, validated per Chinese Pharmacopoeia 2020 and ICH Q1A(R3) Annexes.
Is IQ/OQ documentation included with purchase?

A complete IQ/OQ protocol package—including test scripts, acceptance criteria, and executed reports—is provided; on-site execution services are available upon request.
What is the maximum allowable ambient temperature for installation?

The unit must be installed in environments where ambient temperature remains between 5°C and 35°C, with relative humidity ≤85% RH and adequate ventilation clearance (≥30 cm rear/side spacing).
How is data integrity ensured during power failure?

Internal non-volatile memory retains all logged data; optional UPS integration and GSM-based SMS alerts provide redundancy for critical deviation events.